While we await further studies dedicated to exploring the specific pathologies and activation pathways used by human CD4 versus CD8 T cells in xenogeneic transplantation, these limited but highly interesting studies suggest that CD8 T cells and not CD4 T cells may be the more prominent T cell lineage to study in terms of GVHD pathology. The gene discussed is CD4; the disease is graft versus host disease.